SC 13G
SC 13G Filing
- Company
- Karyopharm Therapeutics Inc.
- Filed
- December 8, 2022
- Accession Number
- 0000919574-22-007017
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →